Professional Summary
Professional Overview
Lisha Wang is a seasoned pharmaceutical industry professional with over 15 years of experience in medicinal chemistry, computational chemistry, and Contract Research Organization (CRO) business operations. As the CADD Head/Medicinal Chemistry/CRO BU at PharmaBlock Sciences (Nanjing), Inc., she leverages her deep expertise in drug discovery and development to drive innovative research and strategic business initiatives.
Experience Summary
Current Role
As the CADD Head/Medicinal Chemistry/CRO BU at PharmaBlock Sciences (Nanjing), Inc., Lisha Wang is responsible for leading the computational chemistry and medicinal chemistry teams, as well as overseeing the CRO business unit. In this role, she has been instrumental in expanding the company's service offerings, strengthening its technical capabilities, and driving strategic collaborations with pharmaceutical partners.
Career Progression
Prior to her current position, Lisha Wang held various research and development roles at F. Hoffmann-La Roche Ltd, where she progressed from Research Investigator to Principal Scientist, contributing to numerous drug discovery projects and patent filings. Her diverse experience also includes an internship in IMP Quality Operations Europe Basel and a stint as a Trainee in the Global Patent Office at F. Hoffmann-La Roche.
Lisha Wang's early career was marked by her roles as a Research Associate Investigator and Senior Scientist at the Roche R&D Center (China) Ltd., where she conducted cutting-edge research and demonstrated her expertise in computational chemistry and medicinal chemistry.
Academic Background
Lisha Wang holds a strong academic background, having completed her education in China. She earned her bachelor's degree and subsequently pursued her doctoral studies, specializing in relevant fields that have equipped her with the scientific expertise and research acumen necessary for her successful career in the pharmaceutical industry.
Areas of Expertise
Lisha Wang's areas of expertise span computational chemistry, medicinal chemistry, and CRO business operations. She has a proven track record of leveraging computational methods, such as CADD, to accelerate drug discovery and optimization processes. Her technical competencies also include lead identification, hit-to-lead optimization, and preclinical candidate selection. Additionally, Lisha's leadership and management skills have been instrumental in driving the strategic growth of the CRO business unit at PharmaBlock Sciences (Nanjing), Inc.
Professional Impact
Throughout her career, Lisha Wang has made significant contributions to the pharmaceutical industry. She has been actively involved in various drug discovery projects, leading to the identification of promising drug candidates and the filing of multiple patents. Her industry impact is further evident in her successful collaborations with pharmaceutical partners, her participation in scientific conferences, and her publications in peer-reviewed journals.
Conclusion
Lisha Wang's impressive career trajectory, combined with her deep expertise in computational chemistry, medicinal chemistry, and CRO business operations, positions her as a highly valuable asset in the pharmaceutical industry. Her leadership, technical prowess, and strategic mindset have enabled her to drive innovation, foster strategic partnerships, and contribute to the advancement of drug discovery and development.
